DOI 10.11604/pamj.2025.51.71.47807
Thyroid-associated orbitopathy following COVID-19: a case report.
Аннотация
Studies have shown a link between COVID-19 vaccination and the development of Graves' disease (GD) and Graves' orbitopathy (GO). However, to the best of our knowledge, this is only the second reported case of clinically overt GO following COVID-19 infection. Herein, we report a 48-year-old female patient who was initially treated in 2017 with radioactive iodine therapy for a toxic thyroid adenoma. In 2021, the patient was diagnosed with COVID-19. Ten days later, she developed bilateral, active, moderate-to-severe GO, accompanied by elevated thyrotropin receptor antibody (TRAb) levels. She was treated with intravenous methylprednisolone followed by oral prednisone and later underwent orbital decompression surgery, followed by strabismus surgery due to worsening diplopia. No complications occurred postoperatively, and her symptoms improved significantly. This case contributes to the literature by suggesting a potential association between COVID-19 infection and the onset of autoimmune diseases, including GO.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.